Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marty Makary
Fierce Pharma
Vinay Prasad is back at the FDA after last month's surprise ouster
“At the FDA’s request,” Vinay Prasad, M.D., is returning to lead CBER, an HHS spokesperson told Fierce Pharma.
Angus Liu
Aug 9, 2025 12:22pm
Fierce Pharma
FDA taps new CDER chief as acting CBER head after Prasad exit
Jul 30, 2025 1:10pm
FDA delays hit clinical trial launch decisions
Jul 30, 2025 10:29am
Fierce Pharma
Vinay Prasad departs FDA amid controversy over gene therapy
Jul 30, 2025 9:33am
FDA shares more than 200 CRLs for now-approved drugs
Jul 10, 2025 10:54am
FDA 'on track' to meet all PDUFA dates, Marty Makary says
Jun 18, 2025 4:00am